Involvement of ATBF1 in liver regeneration and hepatocarcinogenesis

ATBF1参与肝再生和肝癌发生

基本信息

  • 批准号:
    17590636
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

AT motif-binding factor 1 (ATBF1) cDNA was first isolated from HuH-7 human hepatoma cells based on the ability of its products to bind to an AT-rich element in the enhancer of the human alpha-fetoprotein gene. ATBF1 protein belongs to a family of transcription factors containing both homeodomain and zinc finger motifs. Expression of ATBF1 is induced during neuronal and myogenic differentiation, and also observed in immature cells at the base of villi. This study aims to clarify a role of ATBF1 in liver regeneration and hepatocarcinogenesis. First, we have established real-time PCR to measure expression level of ATBF1 mRNA, and examined sequential changes in ATBF1 expression during proliferation of primary cultured rat hepatocytes treated with hepatocyte growth factor. Expression of ATBF1 was suppressed 6 hours after HGF treatment, while cyclin D1 expression was stimulated. To examine ATBF1 expression in hepatic progenitor cells, rats were administered 2-acetylaminofluorene (2-AAF) five times a week for two weeks, followed by partial hepatectomy (PH). In this 2-AAF/PH model, hepatic progenitor cells, so called "oval cells", are observed alongside of portal areas, and HGF stimulates proliferation and hepatic differentiation of these cells. In mature hepatocytes, ATBF1 expression was immunohistochemically observed in the nucleus eight days after PH, whereas ATBF1 was detected in both nucleus and cytoplasm. Additionally, Although HGF treatment decreased nuclear expression of ATBF1 in mature hepatocytes, and ATBF1 expression in the cytoplasm of oval cells was decreased by this treatment. These results suggest that HGF treatment stimulated proliferation and hepatic differentiation of oval cells, and that proliferation of oval cells gradually terminated and differentiation to mature hepatocytes was induced. ATBF1 may play an important role in proliferation or differentiation of hepatic progenitor cells via its intracellular localization.
AT基序结合因子1(ATBF 1)cDNA首先从HuH-7人肝癌细胞中分离,基于其产物与人甲胎蛋白基因增强子中富含AT的元件结合的能力。ATBF 1蛋白属于一个含有同源结构域和锌指结构域的转录因子家族。ATBF 1的表达在神经元和肌源性分化过程中被诱导,并且还在绒毛基部的未成熟细胞中观察到。本研究旨在阐明ATBF 1在肝再生和肝癌发生中的作用。首先,我们建立了实时PCR来测量ATBF 1 mRNA的表达水平,并检查了经肝细胞生长因子处理的原代培养大鼠肝细胞增殖过程中ATBF 1表达的连续变化。HGF处理后6小时ATBF 1的表达受到抑制,而cyclin D1的表达受到刺激。为了检测ATBF 1在肝祖细胞中的表达,对大鼠给予2-乙酰氨基芴(2-AAF),每周5次,持续2周,然后进行部分肝切除术(PH)。在该2-AAF/PH模型中,在汇管区旁边观察到肝祖细胞,所谓的“卵圆细胞”,并且HGF刺激这些细胞的增殖和肝分化。在成熟的肝细胞中,ATBF 1的表达在PH后8天的细胞核中,而ATBF 1在细胞核和细胞质中均被检测到。此外,虽然HGF处理降低了成熟肝细胞中ATBF 1的核表达,但该处理降低了卵圆细胞胞质中ATBF 1的表达。这些结果表明,HGF处理刺激卵圆细胞的增殖和肝分化,并且卵圆细胞的增殖逐渐终止并诱导向成熟肝细胞分化。ATBF 1可能通过其细胞内定位在肝祖细胞的增殖或分化中发挥重要作用。

项目成果

期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, 1-amino acid-defined diet
过氧化物酶体增殖物激活受体-γ 激动剂吡格列酮可抑制喂食缺乏胆碱、1-氨基酸限定饮食的大鼠肝脏中的脂肪积累和纤维化
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Uto H;Nakanishi C;Ido A;et al.
  • 通讯作者:
    et al.
Interleukin-10 or tumor necrosis factor-a polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan..
白细胞介素10或肿瘤坏死因子a多态性与日本高流行区丙型肝炎病毒感染的自然病程。
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kusumoto K;et al.
  • 通讯作者:
    et al.
Interleukin-10 of tumor necrosis lactor-alpna polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan
日本高流行区肿瘤坏死lactor-alpna多态性的白细胞介素10与丙型肝炎病毒感染的自然病程
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kusumoto K;et al.
  • 通讯作者:
    et al.
Early diagnosis potential for hepatocellular carcinoma using the SELDI ProteinChip system
使用 SELDI ProteinChip 系统对肝细胞癌进行早期诊断的潜力
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kanmura S;Uto H;Kusumoto K;Ishida Y;Hasuike S;Nagata K;Hayashi K;Ido A;Stuver SO;Tsubouchi H
  • 通讯作者:
    Tsubouchi H
Hepatocyte growth factor accelerates the proliferation of hepatic oval cells and possibly promotes the differentiation in a 2-acetylaminofluorene/partial hepatectomy model in rats
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IDO Akio其他文献

IDO Akio的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IDO Akio', 18)}}的其他基金

Involvement of osteoactivin in inflammatory hepatocarcinogenesis: analysis of mice lacking osteoacitivin expression
骨激活素参与炎症性肝癌发生:缺乏骨激活素表达的小鼠的分析
  • 批准号:
    22590742
  • 财政年份:
    2010
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of osteoactivin in hepatic injury and repair
骨激活素参与肝损伤和修复
  • 批准号:
    19590763
  • 财政年份:
    2007
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of osteoactivin and its role in hepatocarcinogenesis
骨激活素的功能分析及其在肝癌发生中的作用
  • 批准号:
    14570484
  • 财政年份:
    2002
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene therapy for hepatocellular carcinoma
肝细胞癌的基因治疗
  • 批准号:
    11670516
  • 财政年份:
    1999
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

TRPV2在原发性肝癌中癌变作用的研究
  • 批准号:
    81171933
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目

相似海外基金

Hyperpolarized 13C Metabolic Imaging of Tumorigenesis in the Liver
肝脏肿瘤发生的超极化 13C 代谢成像
  • 批准号:
    10727760
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma
NASH-肝细胞癌免疫治疗反应的决定因素
  • 批准号:
    10735947
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Integrated multiomics analysis to investigate the mechanism of immunotherapy-resistant MAFLD-related hepatocarcinogenesis
综合多组学分析研究免疫治疗耐药性 MAFLD 相关肝癌发生机制
  • 批准号:
    23K07402
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancer
靶向巨噬细胞中的 KLF2 以改善肝细胞癌的免疫检查点治疗
  • 批准号:
    10677187
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development
多功能纳米颗粒平台可预防酒精相关的 HCC 发展
  • 批准号:
    10736984
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Nuclear envelope and predisposition to hepatic neoplasia
核膜和肝肿瘤易感性
  • 批准号:
    10720212
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Define the oncogenic role of Plk1 during hepatocellular carcinoma development using a genetically modified mouse model
使用转基因小鼠模型定义 Plk1 在肝细胞癌发展过程中的致癌作用
  • 批准号:
    10729603
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Function of NF2/Merlin in regulation of the Hippo/Salvador/Warts growth control pathway
NF2/Merlin 在调节 Hippo/Salvador/Warts 生长控制通路中的功能
  • 批准号:
    10826475
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Deciphering the role of NELFE in modulating MYC signaling in HCC
解读 NELFE 在 HCC 中调节 MYC 信号传导的作用
  • 批准号:
    10738028
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Transcriptomic Quantitation of Hepatitis B Virus Surface Antigen from Integration
通过整合对乙型肝炎病毒表面抗原进行转录组定量
  • 批准号:
    10724716
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了